# lung adenocarcinoma (LUAD) - deepseek-v4-flash

- Benchmark system: E2seq + Agent RAG
- Repeat: 3
- Task type: PROGNOSIS
- Tissue / sample source: lung adenocarcinoma tumor tissue
- Comparison or endpoint: overall survival (OS)
- Answer input cohort: Discovery/Core only
- Selected items: 100
- Input fields: gene name, effect size (log2FC/HR), P value, FDR
- E2seq Agent RAG: enabled
- Conversation memory: disabled
- Thinking mode: disabled
- Held-out validation data in prompt/RAG: no
- Model API: DeepSeek / deepseek-v4-flash
- Message SHA-256: a2c9355177479f23c6c81afe1b39ba697ac131cc344bb83120b98e2c6bbfee49
- Response HTTP status: 200
- Prompt tokens: 44978
- Completion tokens: 20980
- Reasoning tokens: 0
- Total tokens: 65958
- API requests reported: 4
- Elapsed seconds: 110.057
- RAG status: reused_or_ready
- RAG records/genes reported: 100
- RAG elapsed seconds: 957.651
- Question handoff seconds: 970.897
- Final benchmark system: E2seq; file rank 3/5; original repeat 3; model vendor: DeepSeek

---
# Multidimensional Interpretation of Prognostic Transcriptomic Results in Lung Adenocarcinoma (LUAD)

## Critical Data-Quality Warning (Must Read First)

Before any biological interpretation, I must flag that the uploaded statistical table contains **technically suspicious values** that dominate the cohort:

- **96 of 100 selected genes are risk-associated (HR > 1)**; only 4 are protective-associated (HR < 1).
- **65 of 100 genes have HR = 5.1847055e+21** (an identical, saturated value at the numerical precision limit), with P = 0 and FDR = 0.
- The overwhelming majority of these extreme-HR genes are **pseudogenes, unannotated loci, RNA genes (RNU, RNY, Y_RNA), lncRNAs (RP11-, CTD-, LINC-), and unmapped Ensembl transcripts** — not protein-coding genes with established function.
- The ledger flags **Y_RNA as "direction-conflict; rows=163"**, indicating massive duplicate-row aggregation for that gene.

These saturated HR values (5.18e+21) with P = 0 and FDR = 0 are **not biologically interpretable effect sizes**; they almost certainly reflect a statistical artifact (e.g., quasi-complete separation in the Cox model, zero-events strata, or extreme expression sparsity in a small subgroup). **The direct statistical evidence for the 65 saturated-HR genes should be treated as unreliable for effect-size interpretation.**

The remaining 35 genes with finite, plausible HR values (0.21–1.48) and non-zero FDR values constitute the **interpretable core** of this analysis. All biological interpretation below is therefore anchored on this interpretable subset, with the saturated-HR genes treated as a data-quality concern rather than as genuine prognostic signals.

---

## 1. Overall Biological Interpretation

After excluding the saturated-HR artifacts, the interpretable prognostic signal in this LUAD cohort is concentrated in a **risk-associated (HR > 1) molecular program** characterized by:

1. **WNT signaling activation** — DKK1 (HR = 1.475, FDR = 3.5e-07), TLE1 (HR = 1.484, FDR = 2.5e-05), and the developmental transcription factors PITX3 (HR = 1.429, FDR = 3.5e-11) and VAX1 (HR = 1.335, FDR = 9.2e-06) collectively point to aberrant activation of developmental/WNT transcriptional programs associated with poor overall survival.

2. **Glycosylation and cell-surface remodeling** — FUT4 (HR = 1.403, FDR = 2.9e-04), KRT6A (HR = 1.390, FDR = 2.8e-04), LDLRAD3 (HR = 1.420, FDR = 2.2e-04), and RHCG (HR = 1.290, FDR = 4.7e-04) suggest altered cell-surface glycan composition and cytoskeletal remodeling linked to aggressive tumor behavior.

3. **Rho-family GTPase and actin cytoskeleton signaling** — RHOF (HR = 1.403, FDR = 4.0e-04) and RGS20 (HR = 1.352, FDR = 5.8e-04) indicate dysregulated small GTPase signaling and G-protein regulatory activity associated with poor prognosis.

4. **A protective, likely composition-related signal** — RBMXP1 (HR = 0.212, FDR = 1.6e-17), CRNDE (HR = 0.716, FDR = 1.0e-04), and CMAHP (HR = 0.706, FDR = 5.8e-04) are the only interpretable protective genes. Their heterogeneity (an RNA-binding protein pseudogene, a lncRNA, and a pseudogene of complement regulatory protein) makes a unified protective mechanism **unlikely**; these may reflect technical artifacts or cell-composition effects rather than a coherent protective program.

The overall picture is that **poor overall survival in LUAD is associated with a WNT/developmental transcription factor program, altered glycosylation, and Rho-GTPase signaling**, but the interpretable signal is restricted to a minority of the cohort, and the dominant statistical signal (saturated HR values) is not biologically interpretable.

---

## 2. Core Biological Programs

### Program 1: WNT/Developmental Transcription Factor Signaling

- **Direction:** Risk-associated (higher expression → worse OS)
- **Supporting genes:** DKK1 (HR = 1.475, FDR = 3.5e-07), TLE1 (HR = 1.484, FDR = 2.5e-05), PITX3 (HR = 1.429, FDR = 3.5e-11), VAX1 (HR = 1.335, FDR = 9.2e-06)
- **Pathway:** GO: Regulation of Wnt signaling pathway (GO:0030111); KEGG: Wnt signaling pathway; Reactome: Wnt signaling
- **Rationale:** DKK1 is a canonical WNT pathway antagonist whose elevated expression in tumors often reflects feedback activation of WNT/β-catenin signaling. TLE1 is a transcriptional corepressor that modulates WNT and Notch target gene expression. PITX3 and VAX1 are homeodomain transcription factors involved in embryonic development whose aberrant re-expression in tumors is associated with dedifferentiation and poor prognosis. The co-occurrence of multiple developmental transcription factors with WNT pathway components suggests a coherent "developmental reactivation" program.
- **Evidence strength:** Moderate. Four independent genes with FDR < 3.5e-04 support this program. However, this is **not** a formal pathway enrichment result — no GSEA or over-representation statistic was computed on this cohort. The pathway annotations (GO:0030111, KEGG Wnt) are retrieved contextual annotations, not cohort-specific enrichment statistics.
- **Limitations:** DKK1 and TLE1 have pleiotropic functions beyond WNT signaling. PITX3 and VAX1 are not canonical WNT pathway members; their inclusion is based on developmental biology and co-expression plausibility, not direct pathway membership.

### Program 2: Cell-Surface Glycosylation and Glycan Remodeling

- **Direction:** Risk-associated
- **Supporting genes:** FUT4 (HR = 1.403, FDR = 2.9e-04), LDLRAD3 (HR = 1.420, FDR = 2.2e-04), RHCG (HR = 1.290, FDR = 4.7e-04), KRT6A (HR = 1.390, FDR = 2.8e-04)
- **Pathway:** KEGG: Mannose type O-glycan biosynthesis; KEGG: Glycosphingolipid biosynthesis
- **Rationale:** FUT4 encodes a fucosyltransferase that modifies cell-surface glycans, and its overexpression is associated with altered Lewis antigen expression and tumor aggressiveness in several cancers. LDLRAD3 is a LDL receptor family member involved in cell-surface receptor trafficking. RHCG is a Rhesus blood group family ammonia transporter expressed on cell membranes. KRT6A is a keratin whose expression changes accompany epithelial remodeling. Together these genes suggest altered cell-surface composition and glycosylation associated with poor survival.
- **Evidence strength:** Moderate. Four genes with FDR < 4.7e-04. The retrieved KEGG annotations (mannose O-glycan, glycosphingolipid biosynthesis) are contextual pathway records, not cohort enrichment statistics.
- **Limitations:** These genes are functionally heterogeneous; FUT4 is the only direct glycosyltransferase. RHCG and KRT6A are not canonical glycan pathway members. The pathway link is inferential, not statistically established.

### Program 3: Rho-Family GTPase and G-Protein Signaling

- **Direction:** Risk-associated
- **Supporting genes:** RHOF (HR = 1.403, FDR = 4.0e-04), RGS20 (HR = 1.352, FDR = 5.8e-04)
- **Pathway:** GO: Regulation of small GTPase mediated signal transduction; Reactome: G alpha (i) signalling events; G alpha (z) signalling events
- **Rationale:** RHOF (RhoF) is a Rho-family GTPase involved in actin cytoskeleton organization, cell migration, and signal transduction (per QuickGO annotations). RGS20 is a regulator of G-protein signaling that accelerates GTP hydrolysis on Gα subunits (per MyGene summary and Reactome annotations). The co-occurrence of a Rho GTPase and an RGS protein suggests dysregulated small GTPase signaling affecting cell motility and invasion.
- **Evidence strength:** Moderate for the two genes individually (FDR < 5.8e-04), but **weak as a coherent program** — only two genes support it, and they act on different GTPase families (Rho vs. Gα). This is a program-level hypothesis, not an established pathway.
- **Limitations:** Two genes do not constitute a pathway-level signal. RHOF and RGS20 do not directly interact (STRING records show RGS20 interacting with GNAZ, GNB5, GNAI2, GNAQ — not with RHOF). Their co-occurrence in this cohort is consistent with, but not proof of, a shared GTPase signaling program.

### Program 4: Long Non-Coding RNA / cis-Antisense Transcript Signatures

- **Direction:** Risk-associated (mostly)
- **Supporting genes:** LINC01312 (HR = 1.364, FDR = 3.5e-06), LINC02178 (HR = 1.297, FDR = 9.0e-06), LINC01910 (HR = 1.312, FDR = 3.0e-05), LINC02323 (HR = 1.373, FDR = 8.3e-05), LINC02802 (HR = 1.333, FDR = 1.5e-04), ITGB1-DT (HR = 1.302, FDR = 1.5e-04)
- **Pathway:** No single standardized pathway applies; these are non-coding transcripts with regulatory potential.
- **Rationale:** Multiple intergenic and cis-antisense lncRNAs are associated with poor OS. ITGB1-DT has prior literature support in LUAD: a bioinformatics study (PMID 34906142) proposed the ITGB1-DT/ARNTL2 axis as a novel biomarker in LUAD, and another study (PMID 37690573) linked ITGB1-DT to drug-response biomarkers in breast cancer. The recurrence of multiple lncRNAs in the risk-associated group suggests either a genuine non-coding regulatory program or a technical artifact (lncRNA detection is sensitive to library preparation and alignment quality).
- **Evidence strength:** Weak-to-moderate. The individual FDR values are strong (all < 1.5e-04), but no functional program can be assigned without experimental evidence. The literature support for ITGB1-DT in LUAD (PMID 34906142) is contextual and derives from a different cohort/analysis.
- **Limitations:** Most lncRNAs in this cohort (including the saturated-HR ones) have unknown function. Their prognostic association may reflect co-expression with nearby coding genes (cis-effects) rather than independent biological activity.

### Program 5: Protective Signal — RNA-Binding / Pseudogene-Associated

- **Direction:** Protective-associated (higher expression → better OS)
- **Supporting genes:** RBMXP1 (HR = 0.212, FDR = 1.6e-17), CRNDE (HR = 0.716, FDR = 1.0e-04), CMAHP (HR = 0.706, FDR = 5.8e-04)
- **Pathway:** None applicable
- **Rationale:** These are the only interpretable protective genes. RBMXP1 is a pseudogene of an RNA-binding motif protein; CMAHP is a pseudogene of the complement regulatory protein CD46; CRNDE is a lncRNA with reported oncogenic roles in some cancers but protective associations in others. The heterogeneity of these genes makes a unified protective mechanism **implausible**.
- **Evidence strength:** **Weak** as a coherent program. The individual statistics are strong (FDR < 1.0e-04 for RBMXP1 and CRNDE), but no shared biology connects an RNA-binding pseudogene, a complement pseudogene, and a lncRNA.
- **Limitations:** This "program" is likely an artifact of gene annotation (pseudogene mapping) or cell-composition differences rather than a genuine protective biological pathway. It should not be interpreted as evidence of a protective tumor-suppressive program without validation.

---

## 3. Key Genes and Interaction Modules

### Candidate 1: DKK1

- **Statistical direction:** Risk-associated (HR = 1.475, FDR = 3.5e-07)
- **Role in core programs:** WNT signaling (Program 1)
- **Proposed relationships:** DKK1 is a secreted WNT antagonist. Its elevated expression in tumors typically reflects feedback activation of WNT/β-catenin signaling. **Pathway co-membership** with WNT signaling genes is the appropriate relationship descriptor; no direct physical interaction with the other selected genes (PITX3, VAX1, TLE1) is supported by the available evidence.
- **Interaction nature:** Pathway co-membership (WNT signaling); indirect/putative relationship with developmental transcription factors.

### Candidate 2: PITX3

- **Statistical direction:** Risk-associated (HR = 1.429, FDR = 3.5e-11 — the most significant finite-HR gene in the cohort)
- **Role in core programs:** Developmental transcription factor / WNT-adjacent (Program 1)
- **Proposed relationships:** PITX3 is a homeodomain transcription factor. Its relationship to DKK1/TLE1 is **indirect/putative** — both may be part of a broader developmental reactivation program, but no direct regulatory or physical interaction is documented in the available evidence.
- **Interaction nature:** Indirect/putative; co-expression (hypothesized, not demonstrated in this dataset).

### Candidate 3: TLE1

- **Statistical direction:** Risk-associated (HR = 1.484, FDR = 2.5e-05)
- **Role in core programs:** WNT transcriptional modulation (Program 1)
- **Proposed relationships:** TLE1 is a transcriptional corepressor that interacts with TCF/LEF factors in WNT signaling. **Pathway co-membership** with WNT signaling is supported; direct physical interaction with DKK1 or PITX3 is **not** supported by the available evidence.
- **Interaction nature:** Pathway co-membership; regulatory interaction (transcriptional corepressor) — but only with respect to its known partners, not with the other selected genes.

### Candidate 4: FUT4

- **Statistical direction:** Risk-associated (HR = 1.403, FDR = 2.9e-04)
- **Role in core programs:** Glycosylation (Program 2)
- **Proposed relationships:** FUT4 is a fucosyltransferase. STRING records show predicted interactions with B3GNT3 and B4GALT1 (glycosyltransferases), but these are **not among the selected genes** and the evidence is predicted/co-expression-based, not direct physical interaction.
- **Interaction nature:** Pathway co-membership (glycan biosynthesis); indirect relationship with other selected cell-surface genes.

### Candidate 5: RHOF

- **Statistical direction:** Risk-associated (HR = 1.403, FDR = 4.0e-04)
- **Role in core programs:** Rho-GTPase signaling (Program 3)
- **Proposed relationships:** STRING records link RHOF to ACTN1 and ARHGAP1 (actin cytoskeleton regulators). A literature record (PMID 34405015) reports that high RhoF expression predicts worse overall survival in non-M3 acute myeloid leukemia — a **direction-concordant** finding in a different cancer type, but this is external literature evidence, not independent cohort validation for LUAD.
- **Interaction nature:** Direct physical interaction with ACTN1/ARHGAP1 is supported by STRING (predicted, confidence-weighted); relationship to RGS20 is **indirect/putative** (different GTPase families).

### Candidate 6: RGS20

- **Statistical direction:** Risk-associated (HR = 1.352, FDR = 5.8e-04)
- **Role in core programs:** G-protein signaling (Program 3)
- **Proposed relationships:** STRING records show interactions with GNAZ (confidence = 0.952), GNB5 (0.947), GNAI2 (0.820), and GNAQ (0.803). These are **direct physical interaction** records (STRING), but none of these partners are among the selected genes. RGS20's relationship to RHOF is **indirect/putative**.
- **Interaction nature:** Direct physical interaction with Gα subunits (per STRING); indirect relationship to RHOF.

### Candidate 7: ITGB1-DT

- **Statistical direction:** Risk-associated (HR = 1.302, FDR = 1.5e-04, P = 2.071e-07)
- **Role in core programs:** lncRNA signature (Program 4)
- **Proposed relationships:** Literature support exists for ITGB1-DT in LUAD: PMID 34906142 proposes an ITGB1-DT/ARNTL2 axis as a novel biomarker in LUAD (bioinformatics + experimental validation). This is **external literature evidence** from a different cohort, not independent statistical validation of the current dataset.
- **Interaction nature:** Regulatory interaction (antisense transcript to ITGB1) is plausible but not demonstrated in the current dataset; literature co-occurrence with ARNTL2 is reported (PMID 34906142).

### Candidate 8: RBMXP1

- **Statistical direction:** Protective-associated (HR = 0.212, FDR = 1.6e-17 — the most significant protective gene)
- **Role in core programs:** Protective signal (Program 5)
- **Proposed relationships:** RBMXP1 is a pseudogene of an RNA-binding motif protein. Its protective association is statistically strong but biologically unexplained. No interaction evidence is available in the retrieved records.
- **Interaction nature:** None proposed; insufficient evidence for functional relationships.

### Candidate 9: KRT6A

- **Statistical direction:** Risk-associated (HR = 1.390, FDR = 2.8e-04)
- **Role in core programs:** Cell-surface/epithelial remodeling (Program 2)
- **Proposed relationships:** KRT6A is a keratin. A retrieved literature record (PMID 42216026) links KRT6A to mesenchymal stem cell biology and alopecia areata — **not directly relevant** to LUAD prognosis. KRT6A's relationship to FUT4/LDLRAD3 is **indirect/putative** (both reflect epithelial cell-state changes).
- **Interaction nature:** Indirect/putative; co-expression (hypothesized).

### Candidate 10: LDLRAD3

- **Statistical direction:** Risk-associated (HR = 1.420, FDR = 2.2e-04)
- **Role in core programs:** Cell-surface receptor (Program 2)
- **Proposed relationships:** STRING records link LDLRAD3 to APP. This is a **direct physical interaction** record (STRING), but APP is not among the selected genes. LDLRAD3's relationship to FUT4/RHCG is **indirect/putative** (shared cell-surface localization).
- **Interaction nature:** Direct physical interaction with APP (per STRING); indirect relationship to other selected genes.

---

## 4. Validation Priorities

### Priority 1: WNT/Developmental Transcription Factor Program

- **Classification:** Mechanistic hypothesis
- **Why:** DKK1, TLE1, PITX3, and VAX1 constitute the most coherent risk-associated program with multiple independent genes (FDR < 3.5e-04 each).
- **Current dataset evidence:** Four genes with concordant risk direction and significant FDR values.
- **External evidence:** WNT signaling is a well-established oncogenic pathway in LUAD; DKK1 is a documented WNT antagonist with prognostic associations in multiple cancers. However, **external statistical validation was not performed** — no independent LUAD cohort statistic is supplied.
- **Next step:** Perform WNT pathway activity scoring (e.g., GSVA or ssGSEA) in an independent LUAD cohort; validate DKK1/TLE1 expression by qRT-PCR or IHC in a tissue microarray; test whether DKK1 knockdown affects WNT target gene expression and proliferation in LUAD cell lines.
- **Conclusion status:** **Supported hy

E2seq statistical audit: selected=100, ledger=100, RAG records=100, numeric claims checked=64, external claims checked=0, external mismatches=0, status=passed.

Answer model API: deepseek / deepseek-v4-flash.

Source coverage (gene sources = selected items with records / selected RAG items; literature sources = articles / queries)
Online APIs: alliance 53/100 selected items (records returned); cbioportal 51/100 selected items (records returned); chembl 16/100 selected items (records returned); civic 1/100 selected items (records returned); clinicaltrials 6/100 selected items (records returned); clinvar 30/100 selected items (records returned); ensembl 11/100 selected items (partially returned; some queries failed); europepmc 362 articles / initial full-cohort RAG 100 queries + 4 current-round queries; some queries failed; gtex 81/100 selected items (records returned); gwas 100/100 selected items (records returned); hpa 14/100 selected items (records returned); humanbase 56/100 selected items (partially returned; some queries failed); intact 18/100 selected items (records returned); mygene 59/100 selected items (records returned); omnipath 3/100 selected items (records returned); opentargets 55/100 selected items (records returned); pubmed 202 articles / initial full-cohort RAG 100 queries + 3 current-round queries; quickgo 17/100 selected items (records returned); reactome 100/100 selected items (records returned); uniprot 17/100 selected items (records returned)
Local databases: gutmgene 0/100 selected items (reachable but no records for this batch); hmdb 2/100 selected items (records returned); string 14/100 selected items (records returned); trrust 4/100 selected items (records returned)
